Meeting of the Minds: DTRA-JSTO Is Creating a Pipeline for MCM Discovery

Under the Chemical and Biological Defense Program (CBDP), the Department of Defense (DoD) seeks to align novel scientific and technological capabilities for medical countermeasure (MCM) discovery and development against emerging chemical and biological threats. To advance that mission, the Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department in its role as the Joint Science and Technology Office (JSTO) hosted a virtual Planning for Research and Optimization of Medical Investigations and Scientific Engagement (PROMISE) Workshop in January 2021 to engage with DoD labs and Department of Energy (DoE) national laboratories for advanced research and innovation.